272 related articles for article (PubMed ID: 28142068)
1. The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
Yoshimura B; Yada Y; So R; Takaki M; Yamada N
Psychiatry Res; 2017 Apr; 250():65-70. PubMed ID: 28142068
[TBL] [Abstract][Full Text] [Related]
2. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia.
Üçok A; Çikrikçili U; Karabulut S; Salaj A; Öztürk M; Tabak Ö; Durak R
Int Clin Psychopharmacol; 2015 Sep; 30(5):290-5. PubMed ID: 26163875
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
4. Correlation between delay in initiating clozapine and symptomatic improvement.
Yada Y; Yoshimura B; Kishi Y
Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
[No Abstract] [Full Text] [Related]
5. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
[No Abstract] [Full Text] [Related]
7. Antipsychotic prescribing before clozapine in a community psychiatric hospital: a case note review.
Najim H; Heath D; Singh P
Psychiatr Danub; 2013 Sep; 25 Suppl 2():S165-70. PubMed ID: 23995168
[TBL] [Abstract][Full Text] [Related]
8. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
Shah P; Iwata Y; Plitman E; Brown EE; Caravaggio F; Kim J; Nakajima S; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
Psychiatry Res; 2018 Oct; 268():114-122. PubMed ID: 30015109
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
Aissa A; Jouini R; Ouali U; Zgueb Y; Nacef F; El Hechmi Z
Compr Psychiatry; 2022 Jan; 112():152280. PubMed ID: 34763293
[TBL] [Abstract][Full Text] [Related]
10. Use of clozapine in a child with treatment-resistant schizophrenia.
MacEwan TH; Morton MJ
Br J Psychiatry; 1996 Mar; 168(3):376-8. PubMed ID: 8833696
[TBL] [Abstract][Full Text] [Related]
11. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
Nielsen J; Nielsen RE; Correll CU
J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
Grover S; Chakrabarti S; Hazari N; Avasthi A
Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
14. Delay in initiation of clozapine: a retrospective study from a tertiary care hospital in North India.
Grover S; Hazari N; Chakrabarti S; Avasthi A
Psychiatry Res; 2015 Mar; 226(1):181-5. PubMed ID: 25619433
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
Correll CU; Brevig T; Brain C
BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
17. Clozapine use in early psychosis.
Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B
Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463
[TBL] [Abstract][Full Text] [Related]
18. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
Howes OD; Vergunst F; Gee S; McGuire P; Kapur S; Taylor D
Br J Psychiatry; 2012 Dec; 201(6):481-5. PubMed ID: 22955007
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility and Safety of Slower-than-Recommended Titration of Clozapine for Treatment-Resistant Schizophrenia: a Retrospective Cohort Study.
Tsukahara M; So R; Yada Y; Kodama M; Kishi Y
Psychiatr Q; 2021 Jun; 92(2):703-713. PubMed ID: 32889690
[TBL] [Abstract][Full Text] [Related]
20. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
Anderson VM; Goldstein ME; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
